Foresite Capital Management II’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Foresite Capital Management II’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-209,500	Closed	-$943K	–	19
2016 Q1	$943K	Sell	209,500 -500	-0.2%	-$1.85K	0.46%	20
2015 Q4	$1.01M	Sell	210,000 -100,000	-32%	-$567K	0.34%	23
2015 Q3	$1.72M	Buy	+310,000	New	+$2.29M	0.52%	23
2015 Q1	–	Sell	-100,000	Closed	-$1.2M	–	23
2014 Q4	$1.2M	Buy	+100,000	New	+$1.52M	0.82%	21

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Foresite Capital Management II's BDSI Position: Q2 2019 in Review

Foresite Capital Management II sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2019, closing a stake of 717,133 shares — an estimated $3.8M sold.

Foresite Capital Management II first reported a position in BDSI in Q4 2014 and held it in 12 quarters. The position peaked at $5.67M in Q2 2015. 110 funds tracked by Wall St. Rank hold BDSI as of Q2 2019.

Foresite Capital Management II reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2019 after selling out during the quarter.
Foresite Capital Management II sold 717,133 BioDelivery Sciences International, Inc. shares in Q2 2019, an estimated $3.8M.
Foresite Capital Management II first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 12 quarters.
Foresite Capital Management II's BioDelivery Sciences International, Inc. position peaked at $5.67M in Q2 2015.
110 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2019.

Based on Foresite Capital Management II's 13F filing for Q2 2019, filed 13 Aug 2019.